000 01915nam a22003857a 4500
008 240807s20242024 xxu||||| |||| 00| 0 eng d
022 _a2168-8184
024 _aPMC11227298 [pmc]
040 _aOvid MEDLINE(R)
099 _a38975444
245 _aUnmasking the Culprits: A Case of Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis Presenting With Mouth Ulcers and Nosebleeds.
251 _aCureus. 16(6):e61822, 2024 Jun.
252 _aCureus. 16(6):e61822, 2024 Jun.
253 _aCureus
260 _c2024
260 _fFY2025
260 _p2024 Jun
265 _sepublish
265 _tPubMed-not-MEDLINE
266 _d2024-08-07
266 _z2024/07/08 07:46
520 _aHemophagocytic lymphohistiocytosis (HLH) is an aggressive syndrome of excessive immune activation. It usually occurs in children, mainly during the first year of life. Primary hemophagocytic lymphohistiocytosis is more common and usually occurs in immunocompromised patients. Secondary hemophagocytic lymphohistiocytosis, on the other hand, is less common, especially in immunocompetent patients. Here, we intend to present a case of a 55-year-old male patient who had no known immune deficiency, presented with epistaxis, and was found to have Epstein-Barr virus (EBV)-induced hemophagocytic lymphohistiocytosis. Copyright © 2024, Obeidat et al.
546 _aEnglish
650 _zAutomated
651 _aMedStar Washington Hospital Center
656 _aHematology/Oncology
656 _aInternal Medicine Residency
657 _aCase Reports
657 _aJournal Article
700 _aNader, Kamyar
_bMWHC
700 _aObeidat, Ahmad
_bMWHC
_cInternal Medicine Residency
_dMBBS
790 _aObeidat A, Al-Moussally F, Al Aruri DO, ALhomaimat E, Nader K
856 _uhttps://dx.doi.org/10.7759/cureus.61822
_zhttps://dx.doi.org/10.7759/cureus.61822
942 _cART
_dArticle
999 _c14460
_d14460